A Gene Editing Breakthrough
By Tom Ashbrook,
NPR On Point [features Marcy Darnovsky]
| 08. 08. 2017
After the blockbuster announcement a U.S. team successfully edited human embryos come the tough medical and ethical questions. We’ll talk it through.
A first in the U.S.: researchers have now edited the genetic code of viable human embryos, cutting and splicing to avoid defect and disease. The DNA of human embryos. Genetically edited. The edited embryos weren’t implanted in a woman. Weren’t born. But they could have been. New life spared disease, maybe death. How far does this gene editing go? How fast? For whom? And for, or against, what human traits? This hour On Point: editing the code of human life. -- Tom Ashbrook
Guests
Amy Dockser Marcus, health and science reporter for the Wall Street Journal. (@AmyDMarcus)
Dr. Paula Amato, co-author of the study showing successful editing of genes in human embryos. Associate professor of obstetrics and gynecology at Oregon Health & Science University.
Arthur Caplan, professor of bioethics and head of the division of medical ethics at the New York University School of Medicine. (@ArthurCaplan)
Marcy Darnovsky, executive director of...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
